Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-04, Stock:JNJ, The news for the past five days is as follows:
2018-08-27: NEWS1: Health Care Sector Update for 08/27/2018: CNC,WMGI,JNJ,PFE.NEWS2: Health Care Sector Update for 08/27/2018: CNC,WMGI,JNJ,PFE.NEWS3: UPDATE: Johnson & Johnson to Host Investor Conference Call on the Pharmaceutical Business.NEWS4: Health Care Sector Update for 08/27/2018: WMGI,JNJ,PFE.NEWS5: Health Care Sector Update for 08/27/2018: WMGI,JNJ,PFE.NEWS6: Geron Stock Rose 32% in Week Ended August 24.NEWS7: Has Geron Corporation's Stock Been De-Risked?.NEWS8: Has Geron Corporation's Stock Been De-Risked?.NEWS9: Dow Movers: PFE, CAT.NEWS10: Dow Movers: PFE, CAT.NEWS11: Wall Street&apos;s latest bull run: The Greater Philadelphia public companies driving the rising tide.NEWS12: This Company Proves That Thinking Small Can Pay Off Big.NEWS13: Has Geron Corporation&apos;s Stock Been De-Risked?.NEWS14: Sympathy Move: Portola Upgraded After Competitor Reports Sour Data.NEWS15: Johnson & Johnson to Participate in the 2018 Morgan Stanley 16th Annual Global Healthcare Conference.NEWS16: The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, BP, eBay and BCE.NEWS17: The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, BP, eBay and BCE.NEWS18: The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, BP, eBay and BCE.NEWS19: Stocks making the biggest move premarket: TSLA, UAL, TWTR, NFLX & more.NEWS20: Stocks making the biggest move premarket: TSLA, UAL, TWTR, NFLX & more.NEWS21: Johnson & Johnson May Rise 9% on Better Growth.NEWS22: Johnson & Johnson to Host Investor Conference Call on the Phase 3 MARINER and COMMANDER HF Studies for XARELTO®.NEWS23: Bayer, J&J's bid to further widen use of Xarelto hits snag.
2018-08-28: NEWS1: Bayer's Blood Thinner Xarelto Fails in Line Extension Studies.NEWS2: Bayer's Blood Thinner Xarelto Fails in Line Extension Studies.NEWS3: New Rules for This Market: Cramer's 'Mad Money' Recap (Tues. 8/28/18).NEWS4: 3 ETFs for Johnson & Johnson's Healthy Breakout.NEWS5: Why Yum China Holdings, Brooks Automation, and Geron Jumped Today.NEWS6: Why Yum China Holdings, Brooks Automation, and Geron Jumped Today.NEWS7: Bayer&apos;s Blood Thinner Xarelto Fails in Line Extension Studies.NEWS8: AFMD Notches Triple-digit Gains, AXSM Strides Ahead, GERON Abuzz.NEWS9: AFMD Notches Triple-digit Gains, AXSM Strides Ahead, GERON Abuzz.NEWS10: Why Yum China Holdings, Brooks Automation, and Geron Jumped Today.NEWS11: Novartis’s Business Segments in Q2 2018.NEWS12: Why Geron Corporation's Stock Is Charging Higher Today.NEWS13: Why Geron Corporation's Stock Is Charging Higher Today.NEWS14: Why Ionis Pharmaceuticals Stock Is Plummeting Today.NEWS15: 25 Dividend Stocks That Analysts Love the Most.NEWS16: AbbVie's Imbruvica Combo Gets FDA Nod for Rare Lymphoma.NEWS17: AbbVie's Imbruvica Combo Gets FDA Nod for Rare Lymphoma.NEWS18: Dow Movers: JNJ, DWDP.NEWS19: Dow Movers: JNJ, DWDP.NEWS20: Why Geron Corporation&apos;s Stock Is Charging Higher Today.NEWS21: QUAL, JNJ, V, XOM: Large Inflows Detected at ETF.NEWS22: QUAL, JNJ, V, XOM: Large Inflows Detected at ETF.NEWS23: Novartis’s Valuation in August.NEWS24: Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron.NEWS25: Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron.NEWS26: AbbVie&apos;s Imbruvica Combo Gets FDA Nod for Rare Lymphoma.NEWS27: Johnson & Johnson Is Hiring -- and It&apos;s Ginormous News for Geron.NEWS28: [$$] Big pharma takes a gamble on NHS experiment.NEWS29: [$$] Healthcare costs: Britain’s NHS partners with big pharma.
2018-08-29: NEWS1: What Is Implied Volatility And Why Should Investors Care About It?.NEWS2: What Is Implied Volatility And Why Should Investors Care About It?.NEWS3: Health Care Sector Update for 08/29/2018: GKOS,NVS,TLRY,JNJ,XENE.NEWS4: Health Care Sector Update for 08/29/2018: GKOS,NVS,TLRY,JNJ,XENE.NEWS5: Alcon Voluntarily Withdraws CyPass Micro-Stent from Global Market.NEWS6: European Commission Approves Novartis’s Tafinlar/Mekinist Combo.NEWS7: Health Care Sector Update for 08/29/2018: NVS,JNJ,XENE.NEWS8: Health Care Sector Update for 08/29/2018: NVS,JNJ,XENE.NEWS9: 25 Dividend Stocks That Analysts Love the Most.NEWS10: 25 Dividend Stocks That Analysts Love the Most.NEWS11: What Is Implied Volatility And Why Should Investors Care About It?.NEWS12: Novartis’s Alcon in Q2 2018.NEWS13: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for August 30, 2018.NEWS14: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for August 30, 2018.NEWS15: Active Traders Remain Bullish on Healthcare.NEWS16: [$$] Portola Pharmaceuticals Director Scores With Stock Purchase.NEWS17: Indian panel wants Johnson & Johnson to pay compensation over recalled implants.NEWS18: Ketamine is becoming a popular treatment for depression, but it acts like an opioid, study suggests.
2018-08-30: NEWS1: Pfizer’s Quarterly Revenues and Estimates for 2018.NEWS2: Pfizer’s Developments in August.NEWS3: Pfizer’s Stock Performance in August.NEWS4: Why K2M Group Holdings, Inc. Acquired a Higher Price Today.NEWS5: Why K2M Group Holdings, Inc. Acquired a Higher Price Today.NEWS6: AstraZeneca (AZN) Gets EU Nod for New Formulation of Bydureon.NEWS7: AstraZeneca (AZN) Gets EU Nod for New Formulation of Bydureon.NEWS8: Why K2M Group Holdings, Inc. Acquired a Higher Price Today.NEWS9: Better Buy: Johnson & Johnson vs. Merck.NEWS10: Better Buy: Johnson & Johnson vs. Merck.NEWS11: Better Buy: Johnson & Johnson vs. Merck.NEWS12: Morning News Call - India, August 30.
2018-08-31: NEWS1: Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK's HIV Drug in Focus.NEWS2: Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK's HIV Drug in Focus.NEWS3: [$$] Johnson & Johnson Heads Health Care List in Management Top 250.NEWS4: Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK&apos;s HIV Drug in Focus.NEWS5: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 04, 2018.NEWS6: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 04, 2018.NEWS7: From Unilever to Ford, companies in Venezuela cling on by cutting products.

Answer: Decrease